Health Erdafitinib Continues to Show Efficacy in Urothelial Carcinoma Jason Junior Jan 15, 2022 The pan-FGFR tyrosine kinase inhibitor erdafitinib (Balversa) was active and safe in patients with locally advanced or metastatic urothelial…